Condition: Allergic Rhinoconjunctivitis · Sponsor: Wroclaw Medical University
The main objective of the study is to measure and correlate clinical parameters suitable for the assessment of allergen immunotherapy (AIT) with an aluminum hydroxide-adsorbed preparation of house dust mite (Dermatophagoides pteronyssinus/ Dermatophagoides farinae) allergens in adults with moderate to severe allergic rhinitis/rhinoconjunctivitis with or without controlled allergic bronchial asthma caused by house dust mite (HDM) allergens. The assessment of clinical responses will be evaluated following an allergen challenge in allergen exposure chamber (AEC) before and during the course of AIT. Patients' response to therapy will be evaluated as well as in the AEC and by patient's personal environment (Diary).
This description comes directly from the study's public registry record.
Marek M Jutel, prof. · +48731021221 · marek.jutel@all-med.wroclaw.pl
Magdalena E Zemelka-Wiacek, Dr · +48507019921 · magdalena.zemelka-wiacek@umw.edu.pl
Always discuss trial participation with your own doctor first.
| ALL-MED Medical Research Institute | Wroclaw, DL, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06778213